TAO Synergies TAOX
NASDAQ TAOX
$3.39 -0.15 (-4.37%)
As of: Oct 22, 2026 · 3:59 PM EDT

TAO Synergies (TAOX) EBITDA Margin (2025 - 2026)

Updated

TAO Synergies' EBITDA Margin was -1769.80% in Q2 2026, up 74829.24 percentage points from -76599.04% a year earlier but down 1431.05 percentage points from the prior quarter.

Analysis

TAO Synergies (TAOX) EBITDA Margin (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, TAO Synergies' EBITDA Margin was -1013.08% through Jun 30, 2026; for FY2025, it was -3023.98%.

  • Quarterly EBITDA Margin has moved between -76599.04% (Q2 2025) and -338.74% (Q1 2026) over five years.
  • Per Business Quant data, TAOX's EBITDA Margin in the three quarters before Q2 2026 was -338.74% (Q1 2026), -3425.19% (Q4 2025) and -884.44% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 53.49%
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 32.68%
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 49.01%
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 6.02%
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 33.11%
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 46.01%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -124.26%
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 39.16%
10 TAO Synergies 25.11 Mn -836,888.78 - -1,769.80%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,769.80%
Mar 31, 2026 -338.74%
Dec 31, 2025 -3,425.19%
Sep 30, 2025 -884.44%
Jun 30, 2025 -76,599.04%
API Access

TAO Synergies EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TAOX&period=max&api_key=YOUR_API_KEY